NeuroMetrix Inc
NASDAQ:NURO
NeuroMetrix Inc
Income from Continuing Operations
NeuroMetrix Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
NeuroMetrix Inc
NASDAQ:NURO
|
Income from Continuing Operations
-$6.5m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is NeuroMetrix Inc's Income from Continuing Operations?
Income from Continuing Operations
-6.5m
USD
Based on the financial report for Dec 31, 2023, NeuroMetrix Inc's Income from Continuing Operations amounts to -6.5m USD.
What is NeuroMetrix Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%
Over the last year, the Income from Continuing Operations growth was -48%. The average annual Income from Continuing Operations growth rates for NeuroMetrix Inc have been -46% over the past three years , and 2% over the past ten years .